Home

Regulated Information

Financial Reports

23

Mar
2023

Annual Report 2022

  • FR

  • FR

24

Mar
2022

Annual Report 2021

  • FR

  • FR

24

Mar
2022

Full Year 2021 Annual Report & Business Highlights

  • FR

06

May
2022

Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights

  • FR

05

Aug
2022

Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights

  • FR

10

Nov
2022

Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights

  • FR

25

Mar
2021

Full Year 2020 Annual Report & Business Highlights

  • FR

31

Mar
2021

Annual Report 2020

  • FR

06

May
2021

First Quarter 2021 Financial Results and Recent Business Highlights

  • FR

04

Aug
2021

Half Year 2021 Financial Results & Business Highlights

  • FR

10

Nov
2021

Third Quarter 2021 Financial Results and Recent Business Highlights

  • FR

22

Mar
2020

Full Year 2019 Annual Report

  • FR

02

Apr
2020

Annual Report 2019

  • FR

07

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

  • FR

06

Aug
2020

Half Year 2020 Financial Results and Business Highlights

  • FR

10

Nov
2020

Third Quarter 2020 Financial Results and Recent Business Highlights

  • FR

28

Mar
2019

Full Year 2018 Financial and Operating Results

  • FR

05

Apr
2019

Annual Report 2018

  • FR

09

May
2019

First Quarter 2019 Financial Results and Recent Business Highlights

  • FR

22

Aug
2019

Interim Financial Report H1.2019

  • FR

19

Nov
2019

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

  • FR

22

Mar
2018

Full year 2017 Financial and Operating Results

  • FR

06

Apr
2018

Annual report 2017

  • FR

15

May
2018

First Quarter 2018 Financial Results and Recent Business Highlights

  • FR

23

Aug
2018

First Half 2018 Financial Results and Operational Progress

  • FR

21

Nov
2018

Third Quarter 2018 Business Update

  • FR

23

Mar
2017

Celyad Reports 2016 Financial and Operating Results

  • FR

19

May
2017

First Quarter 2017 Business Update

  • FR

26

May
2017

Celyad’s Annual Report 2016

  • FR

29

Aug
2017

First Half 2017 Financial statements and operational progress

  • FR

06

Apr
2016

AR 2015 Annual report

  • EN

20

May
2016

Q1 2016 Business Update

  • EN

25

Aug
2016

Celyad 2016 First Half Year Report

  • FR

18

Nov
2016

Q3 2016 Business Update

  • FR

30

Jun
2015

H1 2015 Interim Financial Report

  • FR

19

Nov
2015

Q3 2015 Business Update

  • FR

SEC Filings

Filter

Filing Date Form Description Filing Group Downloads
December 21, 2022 6-K Celyad Oncology Provides An Update On Its Strategic Business Model, Continuing To Focus On Opportunities To Fully Harness The True Potential Of Its Proprietary Technology Platforms And Intellectual Property
November 11, 2022 6-K Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights
September 22, 2022 6-K Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction
August 5, 2022 6-K Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
August 1, 2022 6-K Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial
June 24, 2022 6-K Celyad Oncology Announces Leadership Updates

Regulated Information

Filter

Request for proposal of external statutory Auditor mandate

Uncategorized | December 20th, 2022

Interim Financial Report – First Half 2022

Uncategorized | August 5th, 2022

RAPPORT FINANCIER INTERMEDIAIRE

Uncategorized | August 5th, 2022